GaryNSchwartzMD

Clinical Trials

• Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer Start of enrollment: 1997 May 01

  Completed

  Phase 1

• Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer Start of enrollment: 2004 Jan 01

  Completed

  Phase 2

• Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers Start of enrollment: 2003 Jan 01

  Completed

  Phase 1

• Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function Start of enrollment: 2002 Jul 01

  Terminated

  Phase 2, Phase 3

• Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy Start of enrollment: 2006 Jan 01

  Terminated

  Phase 2

• Phase I Study of Aprotinin in Advanced Breast Cancer Start of enrollment: 2006 Jul 01

  Terminated

  Phase 1

• Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13

  Completed

  Phase 3

• Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16

  Completed

  Not Applicable

• Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic Pathway Start of enrollment: 2012 Dec 01

  Terminated

  Not Applicable

• S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12

  Active, not recruiting

  Phase 3

• Patient Derived Breast Cancer Xenografts Start of enrollment: 2013 Dec 01

  Terminated

• Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer. Start of enrollment: 2014 Jan 01

  Completed

  Not Applicable

• Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2014 May 01

  Completed

  Phase 2

• A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer Start of enrollment: 2021 May 10

  Active, not recruiting

  Phase 3

• Join now to see all